Morningstar adopts Generative AI Index theme as core business evolves

AI For Business


  • Morningstar, ticker NasdaqGS:MORN, has launched the Morningstar Pitchbook GenAI 20 Index, which focuses on purely generative AI companies.
  • The index tracks leading generative AI companies throughout their private-to-public lifecycle, including companies not typically included in major benchmarks.
  • This announcement provides investors with new tools to track and compare activity in the Generative AI sector.

Morningstar introduced the index when its stock was trading at $214.0, with one-year returns down 34.1% and three-year returns down 7.9%. The stock has fallen 4.7% over five years, but has returned 1.7% year-to-date. This combination of short-term stability and long-term decline provides context for companies investing in new index products related to emerging technology themes.

For investors, the PitchBook GenAI 20 Index may serve as a reference point when comparing funds, ETFs, or portfolios that claim exposure to generative AI. While it does not represent a direct investment per se, it helps us track how this part of the market is evolving and how public and private leaders in generative AI are grouped together for analysis.

Stay up to date with Morningstar’s most important news stories by adding them to your watchlist or portfolio. Or explore our community and discover new perspectives on Morningstar.

NasdaqGS:MORN revenue and revenue growth (as of January 2026)
NasdaqGS:MORN revenue and revenue growth (as of January 2026)

How does Morningstar compete against its biggest competitor?

The GenAI 20 Index expands Morningstar’s toolkit for institutions and product publishers looking to leverage generative AI more intensively in both private and public markets. For you, this potentially means a clearer reference point for funds and structured products that rely on private AI leaders, many of which are not yet included in mainstream benchmarks.

Morningstar Narrative, this announcement may apply to your paper

While there is no established narrative for Morningstar here, the launch of this index comes alongside a broader push in research, managed account analysis, and index offerings. Taken together, these initiatives demonstrate that companies are focusing on data, analytics, and benchmarking as core strengths. If you already follow Morningstar’s role in indexing and retirement research, the GenAI 20 Index adds another product that marries these capabilities with high-profile technology themes.

Risks and benefits to keep in mind

  • 🎁 The GenAI 20 index may support new licenses or index-linked products that build on Morningstar’s existing index relationships, such as the UK’s PIMFA agreement.
  • 🎁 PitchBook’s private market data can deepen clients’ reliance on Morningstar datasets across both private and public equity workflows.
  • ⚠️ As generative AI is an early-stage theme, investor interest in pure play exposure may be uneven across cycles, potentially impacting demand for related index products.
  • ⚠️ Indices associated with rapidly evolving technologies may face turnover, classification debates, and methodology scrutiny from professional users.

What to watch next

From here, it’s worth looking at whether asset managers license the GenAI 20 index into ETFs or structured products, and how Morningstar positions it against more traditional benchmarks and retirement research. If you want to see how different investors are framing company stories around AI themes, check out our community narrative hub for different perspectives.

This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.

new: Manage all your stock portfolios in one place

What we created is The ultimate portfolio companion For stock investors, And it’s free.

• Connect an unlimited number of portfolios and see the total in one currency
• Alert you to new warning signs and risks via email or mobile phone
• Track the fair value of stocks

Try our demo portfolio for free

Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email editorial-team@simplywallst.com.



Source link